SuperworthAN2 Therapeutics market cap ANTX
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Oct 23, 2026
- $134M
- Highest close in our data
- $621M
- Jan 2024
AN2 Therapeutics is worth $134M at the close on Oct 23, 2026, at $3.55 a share.
That is up 319% over the last year.
Its highest close in our data was $621M in Jan 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $134M | $28.5M | $226M | +329% |
| 2025 | $31.2M | $29.2M | $43.6M | −27% |
| 2024 | $43M | $29.2M | $621M | −93% |
| 2023 | $609.4M | $98.9M | $615.6M | +230% |
| 2022 | $184.9M | $158.3M | $386.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest AN2 Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| ANTXAN2 Therapeutics | $134M |
| NATRNatures Sunshine Products | $213.8M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| ATNMActinium Pharmaceuticals | $47.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on AN2 Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.